Skip to main content

Advertisement

Springer Nature Link
Log in

The role of antibody in the activation of the alternative complement pathway

  • Published:
Springer Seminars in Immunopathology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Bornstein P (1970) Structure of alpha-1-CB8, a large cyanogen bromide produced fragment from the alpha-I chain of rat collagen. The nature of a hydroxylamine-sensitive bond and composition of tryptic peptides. Biochemistry 9: 2408

    PubMed  Google Scholar 

  2. Capel PJA, Groeneboer O, Grosveld G, Pondman KW (1978) The binding of activated C3 to polysaccharides and immunoglobulins. J Immunol 121: 2566

    PubMed  Google Scholar 

  3. Czop J, Nussenzweig V (1976) Studies on the mechanism of solubilization of immune precipitates by serum. J Exp Med 143: 615

    PubMed  Google Scholar 

  4. Daha MR, Austen KF, Fearon DT (1977) The incorporation of C3 nephritic factor (C3NeF) into a stabilized C3 convertase, C3b, Bb (C3NeF), and its release after decay of convertase function. J Immunol 119: 812

    PubMed  Google Scholar 

  5. Daha MR, Austen KF, Fearon DT (1978) Heterogeneity, polypeptide chain composition and antigenic reactivity of C3 nephritic factor. J Immunol 120: 1389

    PubMed  Google Scholar 

  6. Davis AE III, Arnaout MA, Alper CA, Rosen FS (1977) Transfer of C3 nephritic factor from mother to fetus. Is C3 nephritic factor IgG? N Engl J Med 297: 144

    PubMed  Google Scholar 

  7. Davis AE III, Ziegler JB, Gelfand EW, Rosen FS, Alper CA (1977) Heterogeneity of nephritic factor and its identification as immunoglobulin. Proc Natl Acad Sci USA 74: 3980

    PubMed  Google Scholar 

  8. Edwards MS, Nicholson-Weller A, Baker CJ, Kasper DL (1980) The role of specific antibody in alternative complement pathway-mediated opsonophagocytosis of type III, group Bstreptococcus. J Exp Med 151: 1275

    PubMed  Google Scholar 

  9. Edwards MS, Kasper DL, Jennings HJ, Baker CJ, Nicholson-Weller A (1982) Capsular sialic acid prevents activation of the alternative complement pathway by type III, group B streptococci. J Immunol 128: 1278

    PubMed  Google Scholar 

  10. Eisen HN (1980) Immunoglobulin molecules and genes. In: Davis BD, Dulbecco R, Eisen HN, Ginsberg HS (eds) Microbiology including immunology and molecular genetics, 3rd edn. Harper and Row, Hagerstown, p 337

    Google Scholar 

  11. Ehrnst AC (1975) Characterization of measles virus-specific cytotoxic antibodies by use of a chronically infected cell line. J Immunol 114: 1077

    PubMed  Google Scholar 

  12. Ehrnst A (1978) Separate pathways of C activation by measles virus cytotoxic antibodies: subclass analysis and capacity of F(ab) molecules to activate C via the alternative pathway. J Immunol 121: 1206

    PubMed  Google Scholar 

  13. Ehrnst A, Sundvist K-G (1975) Polar appearance and nonligand induced spreading of measles virus hemagglutinin at the surface of chronically infected cells. Cell 5: 351

    PubMed  Google Scholar 

  14. Fearon DT (1978) Regulation by membrane sialic acid of beta-1-H-dependent decay-dissociation of amplification C3 convertase of the alternative complement pathway. Proc Natl Acad Sci USA 75: 1971

    PubMed  Google Scholar 

  15. Fearon DT, dAusten KF (1977) Activation of the alternative complement pathway due to resistance of zymosan-bound amplification convertase to endogenous regulatory mechanisms. Proc Natl Acad Sci USA 74: 1683

    PubMed  Google Scholar 

  16. Fearon DT, Austen KF (1977) Activation of the alternative complement pathway with rabbit erythrocytes by circumvention of the regulatory action of endogenous control proteins. J Exp Med 146: 22

    PubMed  Google Scholar 

  17. Fearon DT, Austen KF (1980) Current concepts in immunology. The alternative pathway of complement—a system for host resistance to microbial infection. N Engl J Med 303: 259

    PubMed  Google Scholar 

  18. Fleischman JB, Porter RR, Press EM (1963) The arrangement of the peptide chains in gamma-globulin. Biochem J 88: 220

    PubMed  Google Scholar 

  19. Fujita T, Takiuchi M, Iida K, Nagaki K, Inai S (1977) The activation mechanism of the alternative pathway of the human complement system by the immune precipitate formed with F(ab′)2 of rabbit IgG antibody: the generation of C3- and C5-cleaving enzymes on the immune precipitate. Immunochemistry 14: 25

    PubMed  Google Scholar 

  20. Fujita T, Takata Y, Tamura N (1981) Solubilization of immune precipitates by six isolated alternative pathway proteins. J Exp Med 154: 1743

    PubMed  Google Scholar 

  21. Gadd KJ, Reid KBM (1981) Importance of the integrity of the inter-beavy-chain disulphide bond of rabbit IgG in the activation of the alternative pathway of human complement by the F(ab′)2 region of rabbit IgG antibody in immune aggregates. Immunology 42: 75

    PubMed  Google Scholar 

  22. Gadd KJ, Reid KBM (1981) The binding of complement component C3 to antibody-antigen aggregates after activation of the alternative pathway in human serum. Biochem J 195: 471

    PubMed  Google Scholar 

  23. Heidelberger M (1941) Quantitative chemical studies on complement or alexin. I. A method. J Exp Med 73: 681

    Google Scholar 

  24. Heidelberger M, Weil AJ, Treffers HP (1941) Quantitative chemical studies on complement or alexin. II. The interrelation of complement with antigen-antibody compounds and with sensitized red cells. J Exp Med 73: 695

    Google Scholar 

  25. Kazatchkine MD, Fearon DT, Austen KF (1979) Human alternative complement pathway: membrane-associated sialic acid regulates the competition between B and beta-1-H for cell-bound C3b. J Immunol 122: 75

    PubMed  Google Scholar 

  26. Law SK, Levine RP (1977) Interaction between the third complement protein and cell surface macromolecules. Proc Natl Acad Sci USA 74: 2701

    PubMed  Google Scholar 

  27. Law SK, Lichtenberg NA, Levine RP (1979) Evidence for an ester linkage between the labile binding site of C3b and receptive surfaces. J Immunol 123: 1388

    PubMed  Google Scholar 

  28. Law S-KA, Minich TM, Levine RP (1981) Binding reaction between the third human complement protein and small molecules. Biochemistry 20: 7457

    PubMed  Google Scholar 

  29. Miller GW, Nussenzweig V (1975) A new complement function: solubilization of antigen-antibody aggregates. Proc Natl Acad Sci USA 72: 418

    PubMed  Google Scholar 

  30. Moore FD Jr, Fearon DT, Austen KF (1981) IgG on mouse erythrocytes augments activation of the human alternative complement pathway by enhancing deposition of C3b. J Immunol 126: 1805

    PubMed  Google Scholar 

  31. Moore FD Jr, Austen KF, Fearon DT (1982) Antibody restores human alternative complement pathway activation by mouse erythrocytes rendered functionally deficient by pretreatment with pronase. J Immunol 128: 1302

    PubMed  Google Scholar 

  32. Nelson B, Ruddy S (1979) Enhancing role of IgG in lysis of rabbit erythrocytes by the alternative pathway of human complement. J. Immunol 122: 1994

    PubMed  Google Scholar 

  33. Nicholson-Weller A, Daha MR, Austen KF 1981) Different functions for specific guinea pig IgG1 and IgG2 in the lysis of sheep erythrocytes by C4-deficient guinea pig serum. J Immunol 126: 1800

    PubMed  Google Scholar 

  34. Pangburn MK, Müller-Eberhard HJ (1978) Complement C3 convertase: cell surface restriction of beta-1-H control and generation of restriction on neuraminidase-treated cells. Proc Natl Acad Sci USA 75: 2416

    PubMed  Google Scholar 

  35. Pfaffenbach G, Lamm ME, Gigli I (1982) Activation of the guinea pig alternative complement pathway by mouse IgA immune complexes. J Exp Med 155: 231

    PubMed  Google Scholar 

  36. Polhill RB Jr, Newman SL, Pruitt KM, Johnston RB Jr (1978) Kinetic assessment of alternative complement pathway activity in a hemolytic system. II. Influence of antibody on alternative pathway activation. J Immunol 121: 371

    PubMed  Google Scholar 

  37. Polhill RB Jr, Pruitt KM, Johnston RB Jr (1978) Kinetic assessment of alternative complement pathway activity in a hemolytic system. I. Experimental and mathematical analyses. J Immunol 121: 363

    PubMed  Google Scholar 

  38. Reid KBM (1971) Complement fixation by the F(ab′)2-fragment of pepsin-treated rabbit antibody. Immunology 20: 649

    PubMed  Google Scholar 

  39. Sandberg AL, Osler AG, Shin HS, Oliveira B (1970) The biologic activities of guinea pig antibodies. II. Modes of complement interaction with gamma-1 and gamma-2 inununoglobulins. J Immunol 104: 329

    PubMed  Google Scholar 

  40. Sandberg AL, Götze O, Müller-Eberhard HJ, Osler AG (1971) Complement utilization by guinea pig gamma-1 and gamma-2 immunoglobulins through the C3 activator system. J Immunol 107: 920

    PubMed  Google Scholar 

  41. Sandberg AL, Oliveira B, Osler AG (1971) Two complement interaction sites in guinea pig immunoglobulins. J Immunol 106: 282

    PubMed  Google Scholar 

  42. Schenkein HA, Ruddy S (1981) The role of immunoglobulins in alternative complement pathway activation by zymosan. I. Human IgG with specificity for zymosan enhances alternative pathway activation by zymosan. J Immunol 126: 7

    PubMed  Google Scholar 

  43. Schenkein HA, Ruddy S (1981) The role of immunoglobulins in alternative complement pathway activation by zymosan. II. The effect of IgG on the kinetics of the alternative pathway. J Immunol 126: 11

    PubMed  Google Scholar 

  44. Schur PH, Becker EL (1963) Pepsin digestion of rabbit and sheep antibodies. The effect on complement fixation. J Exp Med 118: 891

    PubMed  Google Scholar 

  45. Scott DM, Amos N, Sissons JGP, Lachmann PJ, Peters DK (1978) The immunoglobulin nature of nephritic factor (NeF). Clin Exp Immunol 32: 12

    PubMed  Google Scholar 

  46. Sim RB, Twose TM, Paterson DS, Sim E (1981) The covalent-binding reaction of complement component C3. Biochem J 193: 115

    PubMed  Google Scholar 

  47. Sissons JGP, West RJ, Fallons J, Williams DG, Boucher BJ, Amos N, Peters DK (1976) The complement abnormalities of lipodystrophy. N Engl J Med 294: 461

    PubMed  Google Scholar 

  48. Sissons JGP, Cooper NR, Oldstone MBA (1979) Alternative complement pathway-mediated lysis of measles virus infected cells: induction by IgG antibody bound to individual viral glycoproteins and comparative efficacy of F(ab′)2 and Fab′ fragments. J Immunol 123: 2144

    PubMed  Google Scholar 

  49. Sissons JGP, Oldstone MBA, Schreiber RD (1980) Antibody-independent activation of the alternative complement pathway by measles virus-infected cells. Proc Natl Acad Sci USA 77: 559

    PubMed  Google Scholar 

  50. Spitzer RE, Vallota EH, Forristal J, Sudora E, Stitzel A, Davis NC, West CD (1969) Serum C'3 lytic system in patients with glomerulonephritis. Science 164: 436

    PubMed  Google Scholar 

  51. Takahashi M, Tack BF, Nussenzweig V (1977) Requirements for the solubilization of immune aggregates by complement. Assembly of a factor B-dependent C3-convertase on the immune aggregates complexes. J Exp Med 145: 86

    PubMed  Google Scholar 

  52. Vallota EH, Forristal J, Spitzer RE, Davis NC, West CD (1970) Characteristics of a non-complement dependent C3-reactive complex formed from factors in nephritic and normal serum. J Exp Med 131: 1306

    PubMed  Google Scholar 

  53. Winkelstein JA, Shin HS (1974) The role of immunoglobulin in the interaction of pneumococci and the properdin pathway: evidence for its specificity and lack of requirement for the Fc portion of the molecule. J Immunol 112: 1635

    PubMed  Google Scholar 

  54. Winkelstein JA, Shin HS, Wood WB Jr (1972) Heat labile opsonins to pneumococcus. III. The participation of immunoglobulin and of the alternate pathway of C3 activation. J Immunol 108: 1681

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Harvard Medical School, USA

    William D. Ratnoff, Douglas T. Fearon & K. Frank Austen

  2. Department of Rheumatology and Immunology, Brigham and Women's Hospital, 617 Seeley G. Mudd Building, 250 Longwood Avenue, 02115, Boston, MA, USA

    William D. Ratnoff, Douglas T. Fearon & K. Frank Austen

Authors
  1. William D. Ratnoff
    View author publications

    You can also search for this author inPubMed Google Scholar

  2. Douglas T. Fearon
    View author publications

    You can also search for this author inPubMed Google Scholar

  3. K. Frank Austen
    View author publications

    You can also search for this author inPubMed Google Scholar

Additional information

Postdoctoral fellow, National Research Service Award T32-AM-07031 from the National Institutes of Health

This work was supported in part by grants AI-07722, AI-10356, and AI-17917 from the National Institues of Health

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ratnoff, W.D., Fearon, D.T. & Austen, K.F. The role of antibody in the activation of the alternative complement pathway. Springer Semin Immunopathol 6, 361–371 (1983). https://doi.org/10.1007/BF02116280

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02116280

Keywords